Loss of U.S. aid has caused community care interruptions that have increased the risk of drug-resistant tuberculosis in India, according to Think Global Health. Without donor-funded community programs, patients are far more likely to fall through the cracks, even when medicines are technically free, putting years of progress in reducing stigma and improving treatment completion at risk.

According to Forbes, the dismantling of USAID and the U.S. exit from the World Health Organization have left a significant leadership and funding gap in global health initiatives. Without renewed American engagement or alternative governance models, weakened health systems and unmet needs in vulnerable countries could widen, forcing a rethinking of how global health priorities are funded and led.

Health Policy Watch reports that one year after the U.S. government paused foreign aid and cut global health projects, gaps continue to emerge in services such as HIV treatment. These changes were a major shock to global health financing and governance, with models estimating significant deaths and disease spread associated with the funding interruptions.

A pan-African HIV vaccine trial originally set to begin with substantial U.S. funding was thrown into jeopardy last year when foreign aid was abruptly cut. According to NPR, even amid those setbacks and a reduced scope, the downsized trial has now started enrolling participants, offering cautious hope that advancing vaccine research.

Essential health efforts have been hobbled in many low- and middle-income nations, leaving care gaps and forcing governments to explore new funding strategies, reports Think Global Health.

After U.S. aid cuts disrupted malaria treatment in northern Cameroon, clinics ran short of lifesaving drugs and unpaid health workers struggled to fill the gaps. The New York Times investigates how quickly progress against malaria can unravel when supply chains and frontline care are broken.

NPR reports that years of progress against neglected tropical diseases — driven largely by U.S.-backed mass drug distribution and surveillance programs — are now at risk as funding cuts disrupt treatment campaigns.

ProPublica traces how abrupt U.S. policy decisions, including aid freezes and program terminations, triggered food shortages across fragile regions, compounding conflict and displacement. Internal documents and interviews show the crisis was widely anticipated but allowed to unfold anyway.

ProPublica reveals how U.S. officials marked major aid cuts even as warnings mounted about disease outbreaks. In the weeks that followed, cholera spread in vulnerable communities, underscoring the deadly consequences of dismantling public health systems mid-crisis.

The Guardian reports that U.S. funding cuts have shuttered HIV clinics, disrupted PrEP and ART supply chains, and ended community-led outreach across multiple countries. Health workers warn that prevention gains made over two decades are collapsing, with global agencies now projecting a surge in new infections and treatment interruptions that could undo years of progress toward epidemic control.

New modeling suggests that simultaneous U.S. and European aid drawdowns would erase decades of gains against infectious disease. The findings point to a geopolitical vacuum, with no major donor prepared to offset the scale of withdrawn support.

The research warns that reductions in U.S. TB funding could trigger major spikes in pediatric infections. The projections underscore how cuts undermine global outbreak control and shift long-term treatment costs back onto lower-income countries.

New domestic spending in Kenya, Rwanda, and Ethiopia signals resilience, but the move also exposes how heavily the region relied on U.S. support, reports The Guardian. Governments are now filling emergency gaps rather than following planned transition timelines, raising questions about sustainability and equity.

U.S. cuts disrupted HIV treatment continuity, leaving patients vulnerable. Now the U.K.’s proposed reductions threaten to deepen those losses, underscoring how global health systems built over decades can unravel quickly when major donors step back simultaneously.

The investigation links the U.S. retreat to failures across disease surveillance, supply chains, and basic health services. The estimated death toll highlights how dismantling USAID’s global health infrastructure weakens pandemic preparedness and undercuts long-standing U.S. commitments abroad, The New Yorker reports.

In Madagascar, the loss of a USAID-funded health program has left remote communities without care, driving up maternal deaths, malaria, and disease outbreaks.

Somalia’s health system is collapsing under the weight of U.S. withdrawal. Clinics once supported by American aid are now turning away malnourished children.